NAT Run Controls
III. Summary sheet of NAT, nucleic acid Run controls
(I) Certified reference materials
|
Number |
Name |
Approval Number |
Standard Value |
Dimensions |
|
GBDS-BW-001 |
Human cytomegalovirus DNA (HCMV DNA) liquid reference material |
GBW(E)090676 |
（1.8±0.7）E+03 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-002 |
GBW(E)090677 |
（2.0±0.7）E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-003 |
GBW(E)090678 |
（2.4±0.7）E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-004 |
EB virus DNA (EBV DNA) liquid reference material |
GBW(E)090679 |
（5.0±1.8）E+03 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-005 |
GBW(E)090680 |
（5.1±1.1）E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-006 |
GBW(E)090681 |
（5.4±1.0）E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-091 |
Hepatitis B virus DNA (HBV DNA) serum (liquid) reference material |
GBW(E)090991 |
(0.5±0.2）E+02 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-092 |
GBW(E)090992 |
（1.0±0.2）E+02 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-093 |
GBW(E)090993 |
（2.1±0.4）E+02 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-094 |
GBW(E)090994 |
（5.1±0.8）E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-007 |
GBW(E)090664 |
(2.1±0.8）E+03 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-008 |
GBW(E)090665 |
(2.1±0.7）E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-009 |
GBW(E)090666 |
(2.0±0.6）E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-010 |
GBW(E)090667 |
(2.1±0.6）E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-095 |
Hepatitis C virus RNA (HCV RNA) serum (liquid) reference material |
GBW(E) 090978 |
(0.5±0.2）E+02 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-096 |
GBW(E) 090979 |
(1.0±0.3）E+02 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-097 |
GBW(E) 090980 |
(2.1±0.4）E+02 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-098 |
GBW(E) 090981 |
(5.0±0.8）E+02 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-011 |
GBW(E)090659 |
( 1.4±0.7) E+03 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-012 |
GBW(E)090660 |
( 1.2±0.5) E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-013 |
GBW(E)090661 |
( 1.4±0.5) E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-014 |
GBW(E)090662 |
( 1.3±0.5) E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-108 |
Human immunodeficiency virus type 1 RNA (HIV-1 RNA) serum (liquid) reference material |
GBW(E)090982 |
(2.1±0.5）E+02 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-109 |
GBW(E)090983 |
(5.1±0.8）E+02 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-110 |
GBW(E)090984 |
(1.1±0.2）E+03 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-111 |
GBW(E)090985 |
(2.1±0.3）E+03 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-015 |
GBW(E)090663 |
(2.1±0.6）E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-016 |
HPV16 DNA (HPV16 DNA) liquid reference material |
GBW (E)090668 |
(1.1±0.3）E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-017 |
GBW (E)090669 |
（1.2±0.3）E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-018 |
GBW (E)090670 |
（1.1±0.2）E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-019 |
GBW (E)090671 |
（1.1±0.2）E+07 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-020 |
HPV18 DNA (HPV18 DNA) liquid reference material |
GBW (E)090672 |
(1.1±0.4）E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-021 |
GBW (E)090673 |
(1.1±0.3）E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-022 |
GBW (E)090674 |
(1.0±0.3）E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-023 |
GBW (E)090675 |
(1.1±0.3）E+07 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-117 |
Novel Coronavirus (SARS-CoV-2) Pseudoviral nucleic acid reference material |
GBW(E)091132 |
(2.0±0.4)E+02 copies/μL |
0.5mL/ tube,5 tubes/kit |
|
GBDS-BW-118 |
GBW(E)091133 |
(2.0±0.4)E+03 copies/μL |
0.5mL/ tube,5 tubes/kit |
(II) The certified reference material for immunity
|
Number |
Name |
Approval Number |
Standard Value （IU/ml） |
Dimensions |
|
GBDS-BW-051 |
Hepatitis B virus surface antigen (HBsAg) serum (fluid) standard material |
GBW(E)090841 |
(0.23±0.09）IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-052 |
GBW(E)090842 |
(0.51±0.09）IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-053 |
GBW(E)090843 |
(5.07±0.64）IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-054 |
GBW(E)090844 |
(10.0±1.30）IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-055 |
GBW(E)090845 |
(25.0±3.30）IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-056 |
Hepatitis B virus surface antibody (HBsAb) serum (liquid) standard material |
GBW(E)090866 |
(5.1±3.6）mIU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-057 |
GBW(E)090867 |
(10.0±3.0）mIU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-058 |
GBW(E)090868 |
(24.9±4.1）mIU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-059 |
GBW(E)090869 |
(49.8±9.8）mIU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-060 |
GBW(E)090870 |
(100±23）mIU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-061 |
Hepatitis B virus e antigen (HBeAg) serum (liquid) standard material |
GBW(E)090871 |
(1.1±0.2）NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-062 |
GBW(E)090872 |
(2.1±0.1）NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-063 |
GBW(E)090873 |
(4.0±0.4）NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-064 |
Hepatitis B virus e antibody (HBeAb) serum (fluid) standard material |
GBW(E)090846 |
(1.0±0.6）NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-065 |
GBW(E)090847 |
(2.1±0.4）NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-066 |
GBW(E)090848 |
(4.2±0.3）NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-067 |
GBW(E)090849 |
(8.0±0.8）NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-068 |
Hepatitis B virus core antibody (HBcAb) serum (liquid) standard material |
GBW(E)090862 |
(0.5±0.2）IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-069 |
GBW(E)090863 |
(1.0±0.3）IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-070 |
GBW(E)090864 |
(1.5±0.4）IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-071 |
GBW(E)090865 |
(2.0±0.5）IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-072 |
Human immunodeficiency virus Type 1 antibody (anti-HIV-1) Serum (liquid) reference material |
GBW(E)090858 |
(1.1±0.2）NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-073 |
GBW(E)090859 |
(2.0±0.2）NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-074 |
GBW(E)090860 |
(4.1±0.3）NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-075 |
GBW(E)090861 |
(8.0±0.7）NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-076 |
Antibodies to hepatitis C virus (Anti-HCV) serum (liquid) standard Quasi material |
GBW(E)090854 |
(1.1±0.2）NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-077 |
GBW(E)090855 |
(2.0±0.2）NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-078 |
GBW(E)090856 |
(4.1±0.3）NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-079 |
GBW(E)090857 |
(8.0±0.6）NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-081 |
Treponema pallidum antibody (anti -TP) serum (liquid) reference material |
GBW(E)090851 |
(6.0±1.4）mIU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-082 |
GBW(E)090852 |
(12.0±2.8）mIU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-083 |
GBW(E)090853 |
(18.1±4.2）mIU/mL |
0.5mL/ tube, 20 tubes/kit |